ABSTRACT
TGFβ signaling pathways of the bone morphogenetic protein (BMP) subclass are essential for dorsoventral pattern formation of both vertebrate and invertebrate embryos. Here we determine by chromosomal mapping, linkage analysis, cDNA sequencing and mRNA rescue that the dorsalized zebrafish mutant lost-a-fin (laf) is defective in the gene activin receptor-like kinase 8 (alk8), which encodes a novel type I TGFβ receptor. The alk8 mRNA is expressed both maternally and zygotically. Embyros that lack zygotic, but retain maternal Laf/Alk8 activity, display a weak dorsalization restricted to the tail and die by 3 days postfertilization. We rescued the laf dorsalized mutant phenotype by alk8 mRNA injection and generated homozygous laf/alk8 mothers to investigate the maternal role of Laf/Alk8 activity. Adult fish lacking Laf/Alk8 activity are fertile, exhibit a growth defect and are significantly smaller than their siblings. Embryos derived from homozygous females, which lack both maternal and zygotic Laf/Alk8 activity, display a strongly dorsalized mutant phenotype, no longer limited to the tail. These mutant embryos lack almost all gastrula ventral cell fates, with a concomitant expansion of dorsal cell types. During later stages, most of the somitic mesoderm and neural tissue circumscribe the dorsoventral axis of the embryo. Zygotic laf/alk8 mutants can be rescued by overexpression of the BMP signal transducer Smad5, but not the Bmp2b or Bmp7 ligands, consistent with the Laf/Alk8 receptor acting within a BMP signaling pathway, downstream of a Bmp2b/Bmp7 signal. Antibodies specific for the phosphorylated, activated form of Smad1/5, show that BMP signaling is nearly absent in gastrula lacking both maternal and zygotic Laf/Alk8 activity, providing further evidence that Laf/Alk8 transduces a BMP signal. In total, our work strongly supports the role of Laf/Alk8 as a type I BMP receptor required for the specification of ventral cell fates.
INTRODUCTION
A bone morphogenetic protein (BMP)/TGFβ signaling pathway is a key component in the generation of diverse cell types along the dorsoventral axis in vertebrates and invertebrates. BMP signaling activity is thought to act as a morphogen, with different activity levels specifying different cell fates along the dorsoventral axis (Dosch et al., 1997; Jones and Smith, 1998; Knecht and Harland, 1997; Mullins, 1998; Neave et al., 1997; Nguyen et al., 1998b; Wilson et al., 1997). The BMP activity gradient is believed to be generated by the diffusion of dorsally expressed, secreted BMP antagonists into ventral regions. A gradient of BMP antagonists thus produces a reciprocal gradient of BMP activity, with highest BMP activity levels in the most ventral regions of the embryo.
A model for BMP signal transduction has been elucidated (reviewed by Massagué, 1998; Whitman, 1998). The BMP ligands bind as dimers to BMP receptors. The receptors are composed of two distinct classes of transmembrane serine-threonine kinases, type I and type II. The receptors are thought to form a tetrameric complex binding two BMP dimers. Upon binding of the BMP ligands to the receptor complex, the type II receptor phosphorylates and activates the type I receptor. The activated type I receptor then directly phosphorylates the downstream receptor-regulated Smad proteins, Smad1, Smad5, and Smad8, which translocate to the nucleus and regulate the transcription of target genes.
In the zebrafish we and others have identified mutants of several components of a BMP signaling pathway that are involved in dorsoventral pattern formation (Connors et al., 1999; Dick et al., 2000; Fisher et al., 1997; Hild et al., 1999; Kishimoto et al., 1997; Nguyen et al., 1998b; Schmid et al., 2000; Schulte-Merker et al., 1997). Two of the mutants, swirl and snailhouse (snh), are mutations in the bmp2b and bmp7 ligand genes, respectively (Dick et al., 2000; Kishimoto et al., 1997; Nguyen et al., 1998b; Schmid et al., 2000). Null mutants of these two BMP ligands exhibit identical, strongly dorsalized phenotypes, whereby nearly all ventral cell types are absent and a reciprocal expansion of dorsal tissue is observed (Schmid et al., 2000). The maternally and zygotically expressed downstream-acting smad5 gene, when mutated in somitabun (Hild et al., 1999), causes a similar dorsalized phenotype (Mullins et al., 1996; Nguyen et al., 1998b). Mutations in these genes in the mouse either do not cause defects in dorsoventral axis formation or the mutants die at a stage prior to establishment of the dorsoventral axis (Chang et al., 1999; Dudley et al., 1995; Luo et al., 1995; Winnier et al., 1995; Yang et al., 1999; Zhang and Bradley, 1996).
In Drosophila, two bmp family members are required for the specification of dorsal cell fates. Null mutations in the ligand decapentaplegic (dpp), the Bmp2/4 orthologue, eliminate all dorsal structures, whereas null mutations in the ligand screw eliminate only a subset of dorsal structures. Consistent with their distinct roles in pattern formation, these ligands signal through different type I receptors. Dpp functions through Thickveins, whereas Screw signals through Saxophone (Neul and Ferguson, 1998; Nguyen et al., 1998a). In zebrafish, loss-of-function analysis has demonstrated that the ligands encoded by swirl/bmp2b and snh/bmp7 are equally required for specifying ventral cell fates (Schmid et al., 2000). The nature of the receptors through which these ligands signal has not yet been defined genetically.
In this study we determine that the dorsalized zebrafish mutant lost-a-fin (laf) is defective in activin receptor-like kinase 8 (alk8), a novel TGFβ receptor (Yelick et al., 1998). Our findings from rescue experiments with BMP pathway components and analysis with antibodies specific for the phosphorylated form of the BMP signal transducer, Smad1/5, show that Laf/Alk8 acts as a BMP receptor within a Bmp2b/Bmp7 signaling pathway. To investigate the role of maternally expressed laf/alk8 mRNA, we generated homozygous mutant laf/alk8 mothers. Embryos lacking both maternal and zygotic Laf/Alk8 activity display a strongly dorsalized mutant phenotype similar to the strongly dorsalized mutants swirl/bmp2b, snh/bmp7 and somitabun/smad5, demonstrating that the Laf/Alk8 receptor is necessary for the specification of nearly all ventral cell fates in the zebrafish embryo.
MATERIALS AND METHODS
Chromosomal mapping and linkage analysis
Crosses between a TÜ strain containing the laftm110b mutation and either a polymorphic WIK or AB strain were used to generate mapping cross lines. The mapping procedure and the WIK line were described previously (Rauch et al., 1997; Knapik et al., 1996). Pools of about 25 F2laftm110b and wild-type siblings were collected separately and stored in methanol at −20°C. DNA isolation and PCR were performed as described by Gates et al. (Gates et al., 1999), with similar PCR conditions to those described by Connors et al. (Connors et al., 1999).
Single F2 mutant and wild-type embryos from laftm110b mapping cross lines were tested for segregation of the laftm110b mutation from an MspI RFLP in the alk8 3′ UTR. The 3′UTR was amplified by PCR with primers: alk81944F: GAAGCAACAAAAAGGACAGAGACG and alk82598b: AAAAAGAGCAGCGTGAGCATTC.
Cloning of alk8 cDNA and construction of expression vectors
About 50 mutant embryos were collected at 27-30 hours postfertilization (hpf) from a cross between laftm110b heterozygotes. Control wild-type embryos from the TÜ strain (the strain in which the mutation was induced) were also collected at 27-30 hpf. Total RNA was extracted with TRIzol Reagent (Gibco/BRL) according to the manufacturer’s instructions. First strand cDNA was synthesized from total RNA using the Superscript Preamplification System for First Strand Synthesis (Life Technologies). At least two independent PCR reactions were conducted on wild-type or mutant embryo cDNA to isolate the full-length coding region of alk8 (Yelick et al., 1998). The primers used were: alk8147F: CGCTGAGAGTCACTTGAGGAG-TTG and alk81755B: ATAATGAGCGGGTGAGCGGTCAGTAG. PCR conditions were: 94°C, 3 minutes then 40 cycles: 58.5°C, 1 minute; 70°C, 2 minutes; 94°C, 1 minute; followed by 70°C, 20 minutes.
PCR products were subcloned into the pGEM-T Easy Vector System (Promega) according to manufacturer’s instructions. Clones from independent PCR reactions were sequenced using alk8-specific primers. Sequence was analyzed using Sequencer software (Gene Codes Corporation). Sequenced laf/alk8 and laftm110b inserts from pGEM-T Easy vectors were subcloned into the EcoRI site of the expression vector pCS2+ (Rupp et al., 1994).
Genotypic analysis for the laftm110b allele
The missense mutation responsible for the laftm110b allele creates a CfoI site, which was used for genotypic analysis. Genomic DNA was isolated from embryos or adult fish according to the method of Gates et al. (Gates et al., 1999 and Connors et al., 1999). DNA was amplified by PCR with primers alk8.421F CTGCTAGTCATGTGGTAGAAT-GCTG and alk8.498B GCAGTCGAAGTAGGGTCTCTTTGG. The PCR product was digested with CfoI and separated on a 3% MetaPhor agarose (BMA, USA) gel.
mRNA microinjection
p64Tzbmp2 (Nikaido et al., 1997), pCS2+bmp7 (Schmid et al., 2000), and Smad5/pCS2+ (G. R. and M. C. M., unpublished) were linearized with NotI. mRNA was transcribed with the SP6 mMessage mMachine Kit (Ambion). mRNA was injected into the yolk of 1-to 2-cell stage embryos as described by Westerfield (Westerfield, 1995).
Maternal expression of laf/alk8
50 wild-type embryos from the TÜ strain were collected at the one cell stage. Total RNA was extracted and used in first strand cDNA synthesis as described above. laf/alk8 cDNA was amplified by PCR with primers alk8844F: TGTGGAGAGGTCAATGGCAAGG and alk81755B (sequence above).
In situ hybridization
In situ hybridizations were performed as described previously (Schulte-Merker et al., 1992). The probes used were: dlx3 (Akimenko et al., 1995), myoD (Weinberg et al., 1996), foxb1.2 (formerly fkd3) (Odenthal and Nüsslein-Volhard, 1998), krox20 (Oxtoby and Jowett, 1993), gata2 (Detrich et al., 1995), and pax2.1 (Krauss et al., 1992). Embryos were viewed with a Zeiss Axioplan 2 microscope and scanned with a Progress 3012 digital camera (Kontron Elektroniks). Scanned images were processed with Adobe software.
Western blot analysis
Zebrafish embryos were lysed by pipetting in buffer (20 mM Tris pH 8, 50 mM NaCl, 2 mM EDTA, 1 mM NaVO4, 1% NP-40) with added inhibitors (20 μg/ml aprotinin, 40 μg/ml leupeptin, 4 μg/ml pepstatin, 0.75 mM PMSF, 25 mM β-glycerophosphate). Lysates were centrifuged at 14,000 g at 4°C for 10 minutes. Supernatants were transferred to new tubes, and equal volumes of 2× Laemmli sample buffer were added. Before analysis, two volumes of sample buffer were added to ensure solubilization of proteins and to facilitate their optimal separation. Samples (1 embryo equivalent per lane) were subjected to 7.5% SDS-polyacrylimide gel electrophoresis and were analyzed by western blot analysis as described previously (Faure et al., 2000).
Immunohistochemistry
Zebrafish embryos were fixed in 4% paraformaldehyde in PBS overnight. After transfer to PBT (PBS plus 0.1% Triton X-100 and 2 mg/ml BSA), they were manually dechorionated with forceps and were dehydrated stepwise into 100% methanol for storage. After rehydration into PBT and PBTD (PBT plus 1% DMSO), embryos were blocked in PBTD plus 10% normal goat serum (NGS, Jackson ImmunoResearch Laboratories, Inc.) that had been dialyzed against PBS to remove sodium azide. Embryos were then incubated with primary antibody (1:10) in PBTD plus 10% NGS at 4°C overnight. After washing with four changes over 2 hours in PBTD plus 1% NGS, embryos were incubated with secondary goat anti-rabbit IgG-HRP antibody (1:250, Boehringer Mannheim) in PBTD plus 10% NGS for 2 hours at room temperature and washed again. Staining was developed with ImmunoPure Metal-enhanced DAB Substrate Kit (Pierce), as per manufacturer’s instructions, for 1-2 minutes. For microscopy and photography, embryos were cleared in benzyl alcohol:benzylbenzoate (1:2) and then mounted in Canada Balsam:methyl salicylate (9:1). Images were photographed as described above.
RESULTS
lost-a-fin is a mutation in the TGFβ type I receptor alk8
We have previously described mutants of several genes that are essential for specifying ventral regions of the zebrafish embryo. One of these dorsalized mutants not yet characterized is lost-a-fin (laf) (Mullins et al., 1996; Solnica-Krezel et al., 1996), which we examine here. We can first detect the laf zygotic mutant phenotype morphologically at bud stage (end of gastrulation), as a slight protrusion of the tail bud (data not shown). The phenotype becomes more pronounced during somitogenesis, as the tail bud protrudes further and does not extend as far around the yolk as in wild-type embryos, maintaining a more vegetal position than wild type (Fig. 1A,B). At 1 dpf (day postfertilization) laf mutant embryos lack the ventral tail fin and vein (Fig. 1C,D), but display a tail of normal length. Affected embryos fail to develop blood circulation, probably due to loss of the tail vein, and die by 3 dpf.
As a first step to determine the molecular nature of the laf mutation, we mapped the mutation to a chromosomal position using simple sequence length polymorphic (SSLP) markers. We found that the laftm110b mutation is located on linkage group 2 in the 1.3 cM interval between SSLP markers Z21490 and Z11023 (Fig. 2A, data not shown). The TGFβ type I receptor, alk8 (Yelick et al., 1998), had also been linked to Z11023 using a radiation hybrid panel (WashU-Zebrafish Genome Resources Project; Geisler et al., 1999; Fig. 2A). Since other dorsalized mutants had been found to be components of a TGFβ signaling pathway, the linkage of alk8 and laftm110b to the same marker, made alk8 a good candidate for the laf gene.
To test directly if laf corresponds to the alk8 gene, we first examined linkage of alk8 to the laftm110b mutation. We followed the segregation of an RFLP in the 3′ UTR of alk8 in mutant laftm110b and sibling F2 embryos from a mapping cross. In the 96 meioses tested, the polymorphism always segregated with the mutation, placing the laftm110b mutation within 1 cM of the alk8 gene (data not shown).
To determine if laftm110b is a mutation in the alk8 gene, we cloned and sequenced the alk8 cDNA from laftm110b mutant embryos. The alk8 cDNA from mutant embryos contains a single missense mutation, which changes a highly conserved cysteine in the extracellular domain to an arginine residue (Fig. 2B). Type I and type II TGFβ receptors possess 10 characteristic cysteine residues in their extracellular domains (reviewed by Massagué, 1998). The 3 most carboxyl cysteines are highly conserved in their positions relative to the transmembrane domain. The third of these cysteines is altered in the laftm110b mutant. This cysteine has been shown to form an intramolecular disulfide bond in the human type I BMP receptor IA and the murine type II activin receptor (Greenwald et al., 1999; Kirsch et al., 2000). The highly conserved nature of this residue and its presumptive disulfide bond formation in all type I and type II receptors indicates a critical role for it in receptor function. Therefore, substitution of this amino acid is likely to greatly impair receptor activity.
To demonstrate that the laftm110balk8 mutation is responsible for the laf mutant phenotype, we examined the rescuing activity of both wild-type and laftm110b mutant alk8 mRNA following injection into 1-to 2-cell stage laftm110b mutant embryos. We measured rescue as a lessening of the laftm110b mutant phenotype from its class 2 dorsalized phenotype (Fig. 1D), to a weaker class 1 dorsalization or a wild-type phenotype. Wild-type alk8 mRNA rescued the ventral tail mutant phenotypes in greater than 95% of the laf mutant embryos (Fig. 2C). As little as 30 pg of wild-type alk8 mRNA per embryo was sufficient for rescue. In contrast, an almost fivefold larger amount (140 pg/embryo) of mutant laftm110b mRNA failed to rescue laf mutant embryos, thus demonstrating the critical nature of the mutated cysteine residue in laftm110b. The linkage, cDNA sequence analysis, and rescue assays together demonstrate that laftm110b is a mutation in the alk8 gene.
The Laf/Alk8 type I receptor is a component of a BMP signaling pathway
The alk8 gene encodes a novel TGFβ type I receptor, which was first identified by Yelick et al. (Yelick et al., 1998), in the zebrafish. It is most related to Alk2, with 65% overall identity. TGFβ receptors are considerably more divergent in their extracellular domains compared to their intracellular kinase domains. This is also true for Alk8 and human ALK2, which are only 30% identical in their extracellular domains (see also Yelick et al., 1998). In examining the phylogenetic relationship of Alk8 to other TGFβ type I receptors, we find that Alk8 is most closely related to a group of receptors, which include the vertebrate Alk1 and Alk2, and fly Saxophone type I receptors (Newfeld et al., 1999, data not shown). Depending on the nature of the type II receptor, Alk1 can bind activin and TGFβ (Lux et al., 1999; Oh et al., 2000), and Alk2 can bind activin and Bmp7 ligands (Attisano et al., 1993; ten Dijke et al., 1994; Yamashita et al., 1995) and can activate BMP signaling pathways (Armes and Smith, 1997; Faure et al., 2000). Molecular-genetic studies in Drosophila indicate that Saxophone transduces the activity of the Screw and Gbb-60A BMP-related ligands (Haerry et al., 1998; Neul and Ferguson, 1998; Nguyen et al., 1998a). The ability of various TGFβ family ligands to bind or activate these type I receptors brings into question the nature of the signal(s) that Alk8/Laf transduces.
To test whether Laf/Alk8 functions as a component of a BMP signaling pathway, we assayed for the ability of the Bmp2b and Bmp7 ligands and the Smad5 intracellular signal transducer to rescue the laf/alk8 dorsalized mutant phenotype. We reasoned that if Laf/Alk8 is a BMP receptor in this pathway, then the downstream effector, Smad5, is predicted to rescue the laf/alk8 mutant phenotype, whereas the upstream-acting Bmp2b and Bmp7 ligands should not.
We overexpressed bmp2b and bmp7 mRNAs (Nikaido et al., 1997; Schmid et al., 2000) and observed no rescue of laf/alk8 mutant embryos. Approximately the same fraction of mutants was found in the injected as the uninjected embryos (Table 1). One concern in performing these experiments is that the injected mRNA may be degraded by the time tail tissue specification occurs and consequently no rescue would be possible. To control for this possibility, we injected amounts of bmp2b or bmp7 mRNA sufficient to cause duplications of the ventral tail fin in the wild-type sibling embryos (40% and 23% for bmp2b and bmp7, respectively), indicating that the mRNA is present at the time of tail patterning. Moreover, to determine if a small number of mutants was rescued, but not detectable by a significant change in the number of mutant embryos, we genotyped all the non-mutant embryos for the laftm110b mutation in one experiment. We never found a homozygous laftm110b embryo that had a wild-type or ventralized phenotype (0/97 for bmp2b and 0/64 for bmp7; Table 1), consistent with the Laf/Alk8 receptor functioning downstream of the Bmp2b and Bmp7 ligands.
In contrast, injection of smad5 mRNA (G. R. and M. C. M., unpublished) into laf/alk8 mutant embryos reduced the percentage of class 2 dorsalized embryos from an expected 25% to 17.7% (Table 1). This reduction is consistent with smad5 rescuing a fraction of the laf/alk8 mutant embryos. As unambiguous proof that smad5 can rescue laf/alk8 mutant embryos, we genotyped all the class 1 and wild-type embryos from a smad5 injection experiment. All the class 1 embryos and 5% of the phenotypically wild-type embryos (n=101) were laftm110b homozygotes, demonstrating that smad5 can rescue the laf/alk8 dorsalized mutant phenotype. The low fraction of rescued laf/alk8 mutant embryos may be due to the lower activity of the non-phosphorylated, overexpressed smad5. A type I BMP receptor normally phosphorylates and activates Smad5. Therefore, the rescue we observed probably represents the ability of Smad5 to function without phosphorylation when highly overexpressed. Our findings are consistent with the Laf/Alk8 receptor functioning within a BMP signaling pathway and acting downstream of the Bmp2b and Bmp7 ligands and upstream of the receptor-associated Smad, Smad5.
Maternal expression of laf/alk8
The ability of Smad5 to rescue laf/alk8 mutants, while Bmp2b and Bmp7 cannot, raises the possibility that the Laf/Alk8 receptor transduces the Bmp2b and/or Bmp7 signal. However, the bmp2b/swirl and bmp7/snh dorsalized mutant phenotypes are much more severe than the laf/alk8 mutant phenotype, which is restricted to the tail. The different strengths of mutant phenotypes suggest that, (1) Laf/Alk8 may transduce only a subset of the Bmp2b/Bmp7 signal, (2) another receptor functions redundantly to Laf/Alk8 early in development and/or (3) that maternal laf/alk8 expression may be present and functioning early in development. Since other type I TGFβ receptors are maternally expressed (Nikaido et al., 1999a; Nikaido et al., 1999b), we investigated whether laf/alk8 is as well. We examined laf/alk8 mRNA by RT-PCR at the 1-cell stage, well before zygotic transcription commences during the tenth cell cycle (Kane and Kimmel, 1993). Consistent with a previous report (Yelick et al., 1998), we found that laf/alk8 is a maternally expressed message (data not shown).
Rescue of laf/alk8 mutant embryos to homozygous adults
To address the in vivo role of maternal laf/alk8 expression, we sought to generate homozygous laftm110b adult females and analyze their progeny for a maternal-effect mutant phenotype. Such females would produce eggs that lack maternally derived Laf/Alk8 activity. Since laf homozygotes die by 3 dpf, we generated homozygous adults by injecting alk8 mRNA and rescuing mutant embryos from a cross between laftm110b heterozygotes. Phenotypically wild-type embryos at 1 dpf (including >95% of the laf/alk8 mutants) were raised to adults and then genotyped for the laftm110b allele. Of the 149 fish genotyped, 147 were either laftm110b heterozygotes or wild type and only two fish were laftm110b homozygotes. This number is significantly below the expected 25% or 37 homozygotes. In addition, the laftm110b homozygotes identified were runts, about two-thirds the size of their siblings (Fig. 3A,B). We then selectively genotyped the small fish from approximately 1000 embryos injected and raised to adults and found that eight of 15 small fish were laftm110b homozygotes.
To date all ten of the identified laf/alk8 homozygotes are runts. We have assayed growth capacity of the small homozygotes by growing them and similarly sized small, non-mutant siblings in parallel under ideal growth conditions. Homozygotes remained small, while their similarly sized siblings achieved normal size within 2 months, suggesting that the homozygotes have an intrinsic growth defect that persists into adulthood. It is likely that this defect is caused by loss of Alk8/Laf activity, rather than a second linked mutation. Based on the number of fish we genotyped, a second mutation would have to lie within approx. 1.3 cM of laftm110b, which is highly improbable based on the mutation frequency used in the original ENU mutagenesis procedure that induced this mutation (Mullins et al., 1994). In addition to their small size, some homozygotes exhibit an enlargement in the region of the heart (3/10) and swirl when they swim.
In order to gain insight into the reduction in the number of homozygotes at 3 months of age, we followed the development of rescued homozygous embryos and their siblings. Embryos from an intercross of laftm110b heterozygotes were injected with alk8 mRNA at the 1-to 2-cell stage. Embryos that were phenotypically wild type at 1 dpf were followed for developmental abnormalities until 9 dpf, then sacrificed and genotyped. No consistent, specific abnormalities were observed morphologically in the homozygotes compared to their siblings (heterozygotes and wild types), except that only 29% (8/28) of the homozygotes displayed inflated swim bladders by 9 dpf, compared to 82% (118/144) of the non-mutant siblings. Lack of swim bladder inflation is a frequent secondary effect of a mutation. These results suggest that there is a defect in some homozygotes occurring prior to 9 dpf that we did not detect morphologically.
Maternal-zygotic laf/alk8 mutants are strongly dorsalized
To determine the role of maternally and zygotically derived Laf/Alk8 (MZ-Laf/Alk8) activity, we examined the progeny from crosses between homozygous females and males. Such MZ-laf/alk8 mutant embryos display a phenotype morphologically similar to the class 5 swirl/bmp2b mutant phenotype (Mullins et al., 1996). The phenotype is apparent by 95% epiboly and is quite striking by the 1-somite stage; mutant embryos are ovoid rather than round and the notochord appears broadened (Fig. 4A-D). The phenotype becomes more dramatic during somitogenesis, when the somites are expanded mediolaterally and the second and more posterior somites extend from the notochord to the ventral side where they fuse (Fig. 4E,F). The embryos die between the approx. 15-somite stage and 24 hpf, similar to swirl/bmp2b and snh/bmp7 null mutant embryos (Mullins et al., 1996; Schmid et al., 2000).
Crosses between homozygous laftm110b females and wild-type males demonstrate that there is no strict maternal function for Laf/Alk8. All embryos from such crosses display a wild-type phenotype. Thus, zygotic expression of laf/alk8 is sufficient to compensate for the loss of maternal laf/alk8 activity during early development. Similarly, maternal laf/alk8 expression can substitute for some, but not all zygotic laf/alk8 expression, since weak dorsalized mutants are observed in 25% of the progeny of crosses between heterozygotes. Only loss of both maternal and zygotic activity reveals the full extent of Laf/Alk8 function in early development.
We examined the expression of a variety of marker genes by whole-mount in situ hybridization to determine the strength of the dorsalization in MZ-laf/alk8 mutant embryos. At the approx. 5-somite stage, we investigated the expression of myoD in the somitic mesoderm (Weinberg et al., 1996) and pax2.1 in the pronephric system (Krauss et al., 1992) as markers of dorsal and ventral mesodermal derivatives, respectively. At this stage, myoD is expressed in 2 stripes of adaxial cells and in medial-lateral stripes of somitic mesoderm (Fig. 5A; Weinberg et al., 1996). In MZ-laf/alk8 mutant embryos, the myoD adaxial stripes are present and relatively normal, while the first medial-lateral somite stripe is dramatically expanded laterally and all subsequent stripes circumscribe the embryo (Fig. 5C), consistent with the morphology of live mutant embryos (Fig. 4F). In contrast to the expanded dorsal mesoderm, we found pax2.1 expression absent from the pronephric system, a ventral mesodermal derivative (Fig. 5A,C,D).
We investigated the expression of krox20 in rhombomeres 3 and 5 of the hindbrain (Oxtoby and Jowett, 1993), and pax2.1 in the midbrain/hindbrain boundary, both of which are dorsal ectodermal derivatives. We found that prospective rhombomeres 3 and 5 are expanded, encircling the dorsoventral axis of MZ-laf/alk8 mutant embryos (Fig. 5B-D). The mid/hindbrain boundary expression of pax2.1 is also expanded laterally, but only circumscribes a minority of MZ-laf/alk8 mutant embryos (Fig. 5B,D, data not shown). In contrast, in null mutant swirl/bmp2b and snh/bmp7 embryos, both the midbrain and hindbrain tissues extend circumferentially around the axis (Nguyen et al., 1998b; Schmid et al., 2000). Thus, MZ-laf/alk8 mutants are less strongly dorsalized than null swirl/bmp2b and snh/bmp7 mutants.
To determine if the dorsalization observed during somitogenesis stages in MZ-laf/alk8 mutant embryos is caused by changes in pattern formation during gastrulation, we investigated the expression of dorsal and ventral gastrula markers. We found that during mid-gastrulation stages (70% epiboly) the expression of the dorsal marker foxb1.2 (formerly fkd3; Odenthal and Nüsslein-Volhard, 1998,) is expanded laterally and encircles the embryo in marginal regions (Fig. 5E-H). Similar to swirl/bmp2 and snh/bmp7 mutants (Mullins et al., 1996), the expression of goosecoid in the most dorsal-anterior mesoderm appears normal, indicating that the most dorsal mesoderm is not affected (Fig. 5I-L). We examined the expression of dlx3 and gata2 at 70% epiboly, which are expressed in the ventral non-neural ectoderm (Akimenko et al., 1994; Detrich et al., 1995). In MZ-laf/alk8 mutant embryos gata2 expression is absent (Fig. 5I,J). In most MZ-laf/alk8 mutants dlx3 expression is absent, while in the remaining embryos it is severely reduced (Fig. 5K,L; data not shown). The expansion of gastrula dorsal tissue accompanied by a reduction in ventral tissue indicates that MZ-laf/alk8 mutant embryos are defective at gastrula stages in dorsoventral pattern formation. The strength of the patterning defect appears to be intermediate between null mutant swirl/bmp2 or snh/bmp7 embryos and hypomorphic snhty68a mutants (Nguyen et al., 1998b).
Reduced signaling through Smad1/5 in MZ-laf/alk8 mutants
Our overexpression results with BMP pathway components, together with genetic and phenotypic analyses, indicate that laf/alk8 encodes a receptor that participates in BMP signaling during dorsoventral patterning. To examine directly how activation of the BMP signaling pathway is affected in MZ-laf/alk8 mutants, we investigated the amount and spatial distribution of phosphorylated Smad1 and Smad5, the intracellular transducers of BMP signaling, during gastrulation. Antibodies that specifically detect the carboxy-terminal, activating phosphorylations of Smad1 and Smad2 proteins at conserved SSXS motifs have been characterized and shown to be specific (Persson et al., 1998). In Xenopus embryos, endogenous Smad1 phosphorylation is enhanced by overexpression of BMP ligands or constitutively active Alk2* or Alk3* receptors, and is inhibited by overexpression of the truncated BMP receptor ΔBRK or the extracellular BMP antagonist Noggin (Faure et al., 2000). Smad1 and Smad5 share identical C-terminal epitopes, and the anti-phosphoSmad1 antibody also recognizes phosphoSmad5 (M. W., unpublished). Phospho-specific Smad1/5 antibodies can therefore be used to visualize the level of activity, temporal regulation, and spatial distribution of BMP signals in early embryos.
Levels of phosphoSmad1/5 and phosphoSmad2 were examined by western blot analysis in gastrula stage wild-type and MZ-laf/alk8 mutant embryos collected at shield stage, 70% epiboly, and 90% epiboly. In western blot analysis, two bands are detected by anti-Smad1/5 antibodies in lysates of zebrafish embryos from 128-cell to 20-somite stages (Fig. 6A and not shown). The anti-Smad1/5 and anti-phosphoSmad1/5 antibodies recognize conserved epitopes on Smad1 and Smad5, but do not recognize Smad2, Smad3 or Smad4. Since only Smad5 is known to be expressed at pre-shield stages (Dick et al., 1999; Müller et al., 1999) and the doublet detected by anti-Smad1/5 is present as early as the 128-cell stage, we tentatively suggest that the doublet detected at early stages represents posttranscriptionally modified forms of Smad5. At gastrula stages, when both Smad1 and Smad5 are expressed (Dick et al., 1999; Hild et al., 1999; Müller et al., 1999), this doublet may represent the superimposition of posttranscriptionally modified Smad5 and Smad1. The nature of the putative modification resulting in distinctly migrating forms of Smad5 is not known, but these isoforms appear to be identically regulated by BMP signaling. We find that Smad1/5 phosphorylation is maximal in wild-type embryos at 70% epiboly, whereas Smad2 phosphorylation is maximal earlier at 50% epiboly.
In MZ-laf/alk8 mutant embryos, phosphoSmad1/5 levels are markedly decreased compared to wild-type controls at all stages examined (Fig. 6A). However, total Smad1/5 protein levels are not altered in MZ-laf/alk8 mutants (Fig. 6A), indicating a defect in the phosphorylation of Smad1/5 proteins. In contrast, Smad2 phosphorylation, which is mediated by an activin/Nodal signaling pathway, is not reduced in these mutant embryos (Fig. 6A), consistent with a specific decrease in BMP signaling in MZ-laf/alk8 mutant embryos. Thus, the Laf/Alk8 receptor is specifically required for normal levels of Smad1/5 phosphorylation, providing strong evidence for Laf/Alk8 acting as a BMP receptor.
We examined the spatial distribution of phosphorylated Smad1/5 at mid-gastrulation (70% epiboly) by immunohistochemical analysis of wild-type and MZ-laf/alk8 mutant embryos (Fig. 6B-E). We observed punctate staining, consistent with the predicted nuclear localization of phosphorylated Smad1/5 (Massagué, 1998 ) (data not shown). In wild-type embryos, phosphorylated Smad1/5 is greatly enriched on the ventral side (Fig. 6B,D). In embryos lacking both maternal and zygotic Laf/Alk8 activity, phosphorylated Smad1/5 is barely detectable (Fig. 6C,E). Smad1/5 phosphorylation, and therefore presumably BMP signaling, are graded across the dorsoventral axis of the zebrafish gastrula, and the maternal-zygotic laf/alk8 mutation disrupts this pattern by substantially decreasing BMP signaling. The Laf/Alk8 receptor is therefore required for the asymmetric distribution of phosphorylated Smad1/5 across the dorsoventral axis of the early zebrafish embryo.
DISCUSSION
lost-a-fin encodes the type I BMP receptor alk8
Several lines of evidence lead us to conclude that laf encodes the type I TGFβ receptor alk8. laf and alk8 are closely linked in the zebrafish genome. The laftm110b allele contains a missense mutation that is predicted to disrupt a disulfide bridge in the extracellular domain of Alk8. This predicted disulfide bond is highly conserved among all type I and type II TGFβ receptors. Furthermore, mRNA overexpression of alk8 rescues the laf dorsalized mutant phenotype, whereas overexpression of the mutant laftm110b mRNA does not.
We conclude that Laf/Alk8 functions as a BMP receptor for the following three reasons. First, the zygotic and maternal-zygotic laf mutant phenotypes are similar to those of known components in a BMP signaling pathway. The loss of the ventral tail fin in zygotic laf mutants is similar to the dominant swirl/bmp2b, the dominant zygotic somitabun/smad5, and the recessive mini fin/tolloid tail fin phenotypes (Connors et al., 1999; Mullins et al., 1996). Furthermore, the strongly dorsalized MZ-laf mutant phenotype displays dorsoventral patterning defects similar to homozygous swirl/bmp2b, somitabun/smad5 and snailhouse/bmp7 mutant embryos (Mullins et al., 1996; Nguyen et al., 1998b; Schmid et al., 2000).
Second, overexpression experiments position Laf/Alk8 between the BMP ligands and their intracellular signal transducer, Smad5. As expected of a BMP receptor, we found that overexpression of upstream-acting Bmp2b/Bmp7 ligands cannot rescue the laf/alk8 mutant phenotype, while a downstream BMP pathway component, Smad5, can rescue the phenotype.
Third, we observed a vast reduction in BMP-related Smad1/5 phosphorylation in MZ-laf mutant embryos, but no decrease in activin-associated Smad2 phosphorylation. Although the alk8 and smad5 genes are expressed ubiquitously throughout gastrula stages (Dick et al., 1999; Müller et al., 1999; Yelick et al., 1998), we show that phospho-Smad1/5 is localized to ventral regions during gastrulation (Fig. 6B,D). This demonstrates that activation of the BMP signaling pathway is ventrally localized, as it is in Xenopus (Faure et al., 2000). Moreover, we show that this asymmetric distribution of phosphoSmad1/5 depends on Alk8/Laf activity (Fig. 6C,E). All of this evidence strongly supports a role for Laf/Alk8 as a type I receptor transducing BMP-specific signals within a gastrula Bmp2b/Bmp7/Smad5 signaling pathway.
The lost-a-fin maternal-zygotic mutant phenotype
Embryos lacking both maternal and zygotic Laf/Alk8 activity display a dramatic expansion of dorsal-laterally derived structures around the circumference of the embryo and a concomitant loss of ventral tissues. This reduction of ventral and expansion of dorsal cell types is reflected in alterations of gene expression during gastrulation and indicates a defect in pattern formation. The strength of the dorsalization in MZ-laf mutants is intermediate between swirl/bmp2b or snh/bmp7 null mutants and a hypomorphic snh/bmp7 mutant, snhty68a. Notable differences between MZ-laf and null swirl/bmp2b and snh/bmp7 mutants are the less severe expansion of the mid/hindbrain boundary and first somite in most MZ-laf mutants, similar to the hypomorphic snhty68a mutant (Mullins et al., 1996; Schmid et al., 2000). During gastrulation in MZ-laf mutants, expression of the dorsal, neuroectodermal marker foxb1.2 circumscribes the dorsoventral axis marginally, but does not do so in the most animal regions (Fig. 5E-H), in contrast to swirl/bmp2b mutants (Nguyen et al., 1998b). Similar to the hypomorphic snhty68a mutant, MZ-laf mutants lack expression of the ventral marker gata2 (Fig. 5I,J), but retain dlx3 expression in a reduced ventral domain in some mutants (Nguyen et al., 1998b). However, the phenotype is stronger than snhty68a mutants in that Krox20 expression in rhombomeres 3 and 5 circumscribe the dorsoventral axis. The MZ-laf mutant phenotype likely represents an intermediate dorsalization between null swirl/bmp2b and snh/bmp7 mutants and the hypomorphic snh/bmp7 mutant, snhty68a.
There are at least two possible reasons why the MZ-laf mutant phenotype is less severe than the swirl/bmp2b and snh/bmp7 null mutant phenotypes. First, it is possible that the laftm110b mutant allele is not a null allele. A second allele of laf, lafm100, exhibits an identical, recessive zygotic mutant phenotype to laftm110b (Solnica-Krezel et al., 1996; unpublished). The lafm100 allele contains a nonsense mutation, predicted to generate a truncated protein lacking the kinase domain (M. Hammerschmidt, personal communication) that we presume represents a null allele. The identical zygotic mutant phenotypes suggest that laftm110b is a null or strong hypomorphic mutation. It is possible that laftm110b is a strong hypomorph with some residual activity that can establish a very small ventral domain in MZ-laf mutant embryos.
A second possible reason for the less severe dorsalization in MZ-laf mutants compared to swirl/bmp2b and snh/bmp7 null mutants is that other type I BMP receptors may function in dorsoventral patterning in the embryo. Two additional BMP type I receptors, BMPR-IA (Alk3) and BMPR-IB (Alk6), are expressed ubiquitously during gastrulation in the zebrafish (Nikaido et al., 1999a; Nikaido et al., 1999b). Either one or both of these receptors may have overlapping functions to Alk8/Laf and/or act independently of Alk8/Laf in dorsoventral patterning. Overexpression of truncated, dominant-negative forms of the BMPR-IA receptor or its homologues cause dorsalized phenotypes in both zebrafish and Xenopus embryos (Graff et al., 1994; Nikaido et al., 1999a; Suzuki et al., 1994). However, the truncated BMPR-IA receptor may also inhibit other type I BMP receptors, including the Alk8 receptor, as found for other dominant-negative proteins. Thus, these experiments do not distinguish between the functions of individual type I BMP receptors. In contrast, our loss of function analysis demonstrates a key role for the Alk8/Laf BMP type I receptor in vertebrate dorsoventral patterning. The near absence of phosphoSmad1/5 throughout gastrulation indicates that nearly all, if not all, gastrula BMP signaling requires Alk8/Laf receptor activity.
The roles of BMP type I receptors in the mouse
In the mouse, mutants of two type I BMP receptors, Alk2 (ActRIA) and Alk3, and one type II BMP receptor (BMPR-II) have been generated (Beppu et al., 2000; Gu et al., 1999; Mishina et al., 1999; Mishina et al., 1995). For all of these mutants a primary defect occurring prior to or very early in gastrulation has made it difficult to determine the role of these BMP receptors in dorsoventral pattern formation. An interesting case, however, is Alk2 mutant embryos, which arrest during gastrulation with a severe deficit in mesoderm formation. When the mesoderm defect in Alk2 receptor mutants is rescued by wild-type extraembryonic tissues, the mutants display a truncation of posterior regions (Gu et al., 1999; Mishina et al., 1999). Some mouse Bmp4 mutants that survive beyond the egg cylinder stage display a similar posterior truncation (Winnier et al., 1995), which could reflect a dorsalization of the embryo. Further studies are required to discern the nature of the posterior truncation. Although it is possible that the Alk2 receptor plays a similar role to zebrafish Alk8/Laf in dorsoventral patterning, it would be interesting to determine the function of an Alk8 orthologue in the mouse.
Evolutionary conservation in dorsoventral patterning
In Drosophila, two BMP type I receptors, Thickveins and Saxophone, act in the transduction of the Dpp and Screw signals, respectively (Neul and Ferguson, 1998; Nguyen et al., 1998a). However, Dpp and Screw together with their respective receptors play non-equivalent roles in dorsoventral pattern formation, unlike the Bmp2b and Bmp7 ligands in the zebrafish. Thickveins and Dpp act in the establishment of all dorsal cell fates, while Saxophone and Screw specify only a subset. Here we show that the Laf/Alk8 receptor, which is more similar to Saxophone phlyogenetically than Thickveins, plays an extensive role in dorsoventral pattern formation, more similar to Thickveins in the fly. It is possible that all Bmp2b and/or Bmp7 signaling acts through the Laf/Alk8 type I receptor in dorsoventral patterning; however, this does not exclude the role of additional type I receptors in this process. In the fly, Thickveins, Saxophone, and two Punt type II receptor subunits are proposed to form a tetrameric complex together with one Dpp and one Screw homodimer (Neul and Ferguson, 1998; Nguyen et al., 1998a). Hence, additional type I receptors may function together with the Alk8/Laf receptor. Further studies are required to determine the roles of other BMP type I receptors in dorsoventral patterning in vertebrates.
Additional roles of lost-a-fin in development
Our rescue of the zygotic laf dorsalized mutant phenotype by alk8 mRNA injection points to at least one additional role for laf /alk8 beyond dorsoventral pattern formation. Non-viable laf mutants that have been rescued for their dorsalized phenotype, exhibit a low rate of swim bladder inflation at 9 dpf compared to sibling controls (29% vs. 82%), without other gross discernable abnormalities. Lack of swim bladder inflation is a common secondary effect of a mutation. In addition, all identified homozygous laf adults are small, developing to about two-thirds the size of their wild-type siblings. Although the rescued, non-viable laf mutants at 9 dpf are of normal size, it is possible that the non-viability defect is related to the later size defect of homozygous laf adults or, alternatively, these defects reflect two independent functional processes.
It is important to note that rescued homozygous swirl/bmp2b and snh/bmp7 mutant embryos survive at rates more comparable to wild type and are of normal size as adults. This difference suggests that Laf/Alk8 is a receptor for a ligand other than Bmp7 or Bmp2b after dorsoventral patterning, or that in the absence of one ligand the other ligand can compensate. None of the mouse BMP ligand or BMP receptor mutants have been reported to exhibit a general growth defect as adults; however, such a function may only be revealed following rescue of an early lethal defect, as we have done here. Interestingly, several C. elegans mutants exhibit a small adult body size and the mutated genes are known components of a BMP signaling pathway (sma-2, sma-3, sma-4, sma-6, daf-4, and dbl-1; reviewed in Patterson and Padgett, 2000). It is possible that the function of the Laf/Alk8 receptor in regulating body size is related to the function of this C. elegans BMP pathway. In summary, our analysis suggests a new developmental function for BMP signaling in general growth or size regulation in vertebrates, a role we are currently investigating.
Acknowledgments
We thank Helena Robinson-Bey and David Cobb for excellent care and maintenance of the fish facility. We thank Matthias Hammerschmidt for communicating results prior to publication. We are grateful to Stephanie Connors, Steve Dinardo, Roland Dosch, Michael Granato, Dan Wagner, and Tony Wiemelt for helpful discussions and critical comments on the manuscript. This work was supported by grants from NICHD to M. W., NIH grant R01-GM56326 to M. C. M., a fellowship from the American Cancer Society to K. A. M. (PF-98-037-01), and a grant from the National Institutes of General Medical Sciences (GM15389) and a UNCF-Merck Graduate Science Research Dissertation Fellowship to M. A. L.